Stockscreener 앱 받기
3.095
25.23%
0.635
Pyxis Oncology Inc 주식(PYXS)의 최신 뉴스
Pyxis Oncology Inc (NASDAQ: PYXS) Share Price, PYXS Stock News, PYXS Share Price & Updates - Kalkine
H.C. Wainwright reiterates Pyxis Oncology stock rating at buy - Investing.com
H.C. Wainwright Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Pyxis Oncology(PYXS) Stock Options Chain | Quotes & News - Moomoo
PYXS Maintains by Leerink Partners -- Price Target Lowered to $7 - GuruFocus
Pyxis Oncology Raises Capital Through Private Placement Financing - TipRanks
Pyxis Oncology (PYXS) director sells 35K shares after option exercise - Stock Titan
Pyxis Oncology Raises $50 Million in Private Placement; Warrants Could Add ~$64 Million - TradingView
Pyxis Oncology (NASDAQ: PYXS) raises up to $114M in private placement to fund MICVO trials - Stock Titan
GordonMD entities report 10,024,909 PYXS shares (PYXS) - Stock Titan
Leerink cuts Pyxis Oncology stock price target on valuation - Investing.com
Leerink cuts Pyxis Oncology stock price target on valuation By Investing.com - Investing.com Canada
Pyxis Oncology, Inc. Financial Disclosures & SEC Filings - TradingView
Pyxis Oncology Secures $114M for MICVO Cancer Trial - AllSci
Pyxis Oncology, Inc. Stock 12‑Month Price Target Raised to $7.14, Implies 137% Upside - TradingView
Latham & Watkins Advises on Pyxis Oncology’s Up to US$114 Million Private Placement Financing - Legal Desire Media and Insights
Latham Advises on Pyxis Oncology Up to Private Placement Financing - Latham & Watkins LLP
William Blair Maintains Pyxis Oncology(PYXS.US) With Hold Rating - Moomoo
Form 144 Pyxis Oncology For: 30 June By Investing.com - Investing.com Australia
[144] Pyxis Oncology, Inc. SEC Filing - Stock Titan
Pyxis Oncology, Inc. (PYXS) announced the completion of a private financing agreement with a total funding amount up to 114 millions dollars. - Bitget
Pyxis Oncology Announces up to $114 Million P - Moomoo
Pyxis Oncology Secures Up to $114 Million Private Placement - marketscreener.com
Pyxis Oncology (PYXS) Secures $50 Million in Private Placement F - GuruFocus
Pyxis Oncology Announces Up To $114 Million Private Placement Financing To Advance Micvo Through Key Clinical Milestones - TradingView
Pyxis Oncology raises $50 million in private placement By Investing.com - Investing.com South Africa
Pyxis Oncology raises $50 million in private placement - Investing.com
Pyxis Oncology announces up to $114M private placement - TipRanks
Pyxis Oncology Announces up to $114 Million Private Placement Financing to Advance Micvo Through Key Clinical Milestones - Moomoo
Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones - 富途牛牛
Pyxis Oncology, Inc.(NasdaqGS:PYXS) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Pyxis Oncology, Inc.(NasdaqGS:PYXS) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Pyxis Oncology, Inc.(NasdaqGS: PYXS) added to Russell 3000E Growth Benchmark - marketscreener.com
PYXS Stock Price, Quote & Chart - ChartMill
Pyxis Oncology, Inc. Actuals & Estimates (NASDAQ:PYXS) - TradingView
PYXS Forecast — Price Target — Prediction for 2027 - TradingView
Pyxis Oncology Inc (PYXS) Institutional Confidence - TradingKey
Pyxis Oncology Inc (PYXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Pyxis Oncology Inc (PYXS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Penny Stocks To Watch For Growth In June 2026 - simplywall.st
Pyxis Oncology StockThursday technicals around key trading levels - AD HOC NEWS
Pyxis Oncology Inc (PYXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Pyxis Oncology Inc (PYXS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Pyxis Oncology Inc (PYXS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Pyxis Oncology (PYXS) Surges 6.8% as Momentum Builds Near Key ResistanceMax Pain Level - dars.gov.et
Pyxis Oncology Inc (PYXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pyxis Oncology Inc (PYXS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Pyxis Oncology Inc (PYXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pyxis Oncology, Inc. Files Form 8-K with SEC Detailing Corporate Information and Emerging Growth Status - Minichart
Pyxis Oncology elects directors and ratifies auditor at annual meeting - Investing.com
Pyxis Oncology elects directors and ratifies auditor at annual meeting By Investing.com - Investing.com UK
Pyxis Oncology Stockholders Approve Directors and Auditor Slate - TipRanks
Pyxis Oncology (PYXS) shareholders elect Class II directors and ratify Ernst & Young as 2026 auditor - Stock Titan
Pyxis Oncology Inc. (PYXS) Q1 2026 Earnings: Narrower Loss Beats Estimates as Stock Rises on Clinical ProgressFree Cash Flow Trends - newsline.com
Analysts See Nearly 3X Upside in Pyxis Oncology (PYXS) - Insider Monkey
PYXS Q1 2026 Earnings: Narrower-Than-Expected Loss Supports Stock UptickEarnings Quality Analysis - newsline.com
Number of shareholders of Pyxis Oncology, Inc. – NASDAQ:PYXS - TradingView
Pyxis Oncology, Inc. - MLQ.ai
1.21%
3.14%
자본화:
|
볼륨(24시간):